Artificial Intelligence and Internet of Things Integration in Pharmaceutical Manufacturing: A Smart Synergy. [PDF]
Background: The integration of artificial intelligence (AI) with the internet of things (IoTs) represents a significant advancement in pharmaceutical manufacturing and effectively bridges the gap between digital and physical worlds.
Kodumuru R +3 more
europepmc +2 more sources
Why Nigeria Must Strengthen its Local Pharmaceutical Manufacturing Capacity
With over 115 registered pharmaceutical manufacturers, Nigeria still depends on other countries for the supply of active pharmaceutical ingredients and excipients.
Melody Okereke +2 more
doaj +2 more sources
Diversification of Pharmaceutical Manufacturing Processes: Taking the Plunge into the Non-PGM Catalyst Pool. [PDF]
Recent global events have led to the cost of platinum group metals (PGMs) reaching unprecedented heights. Many chemical companies are therefore starting to seriously consider and evaluate if and where they can substitute PGMs for non-PGMs in their ...
Zhao H +4 more
europepmc +2 more sources
Benchmarking the Quality Practices of Global Pharmaceutical Manufacturing to Advance Supply Chain Resilience. [PDF]
Over the past several decades, pharmaceutical manufacturing has become increasingly global and supply chains have become longer, more complex, and fragmented.
Fellows M +10 more
europepmc +2 more sources
Continuous Pharmaceutical Manufacturing [PDF]
[...]
Ossi Korhonen
doaj +2 more sources
NK model simulation study of intelligent manufacturing transformation path selection in pharmaceutical manufacturing enterprises [PDF]
Under the wave of Industry 4.0, traditional pharmaceutical manufacturing enterprises are in urgent need of intelligent manufacturing transformation and upgrading, and exploring the optimal realization path of intelligent manufacturing transformation can ...
Wei Zhu +5 more
doaj +2 more sources
Perspectives on the flexibility analysis for continuous pharmaceutical manufacturing processes. [PDF]
Pharmaceutical continuous manufacturing, especially under the context of COVID-19 pandemic, is regarded as an emerging technology that can guarantee the adequate quality assurance and mitigate process risk while guaranteeing the desirable economic ...
Yang W, Qian W, Yuan Z, Chen B.
europepmc +2 more sources
A Comparative Investment Analysis of Batch Versus Continuous Pharmaceutical Manufacturing Technologies. [PDF]
Purpose This study examines the risks and economics associated with investing in continuous (CM) versus conventional batch manufacturing for production of oral solid dosage pharmaceutical (OSD) products in the USA and abroad.
Rossi CV.
europepmc +2 more sources
Pharmaceutical Manufacturing in China Innovation Performance: A Dynamic QCA Analysis Based on the WSR Perspective [PDF]
Wangwang Zhu,1 Shiqi Tao,2 Xiaoying Zhou,1 Rui Fu3 1Department of Rehabilitation and Health Care, Wuxi Higher Health Vocational Technology School, Wuxi, Jiangsu, People’s Republic of China; 2School of Hospital Economics and Management, Anhui University ...
Zhu W, Tao S, Zhou X, Fu R
doaj +2 more sources
The impact of the centralized volume-based procurement policy on Chinese pharmaceutical manufacturing firms' R&D investment: A difference-in-differences approach. [PDF]
Centralized drug procurement is a common practice worldwide to relieve the healthcare burden and promote high-quality development in the pharmaceutical industry.
Fangjun Qiu +4 more
doaj +2 more sources

